Stock Quote. NASDAQ: TBPH. $9.15 -0.045 (-0.49%). Volume :82,731.
Feb 22, 2024 · PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in the CNS Corporate Panel Discussion at the TD Cowen 44th Annual ...
Ordinary Shares is estimated to report earnings on 05/13/2024. The upcoming earnings date is derived from an algorithm based on a company's historical reporting ...
Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines. Learn more.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Feb 14, 2024 · (NASDAQ: TBPH) will report its fourth quarter and full year 2023 financial ... investor.relations@theravance.com 650-808-4045. https://www ...
Dec 21, 2023 · ("Theravance" or the "Company") (NASDAQ: TBPH) today announced the appointment to its Board of Directors of Jeremy Grant, who serves as a ...